Adc Therapeutics Sa
ADCT
Revenue
17.03M
▼-818.00k▼-4.58%
3 Months ChangeAssets
466.90M
▼-40.40M▼-7.96%
3 Months ChangeLiabilities
521.08M
▲5.19M▲1.01%
3 Months ChangeFree Cash Flow
-44.63M
▼-28.22M▼-171.98%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-06
Form 10-Q
ID: 0001628280-24-034999
2024-08-06
Form 8-K
ID: 0001628280-24-034975
2024-06-14
Form 8-K
ID: 0000950103-24-008385
2024-05-14
Form 8-K
ID: 0000950103-24-006646
2024-05-08
Form 8-K
ID: 0000950103-24-006462
2024-05-06
Form 10-Q
ID: 0001628280-24-020450
2024-05-06
Form 8-K
ID: 0001628280-24-020447
2024-04-09
Form 8-K
ID: 0000950103-24-005064
2024-03-13
Form 8-K
ID: 0001628280-24-010785
2024-03-05
Form 8-K
ID: 0000950103-24-003406